Family Breast and Ovarian Cancer
Showing 9976 - 10000 of >10,000
Among Patients With End Stage Renal Disease
Not yet recruiting
- End Stage Renal Disease
-
Taipei, Taiwan
- +1 more
May 17, 2023
Postoperative Ileus, Bowel Paralysis Trial (Gastric electric pacemaker)
Not yet recruiting
- Postoperative Ileus
- Bowel Paralysis
- Gastric electric pacemaker
- (no location specified)
Feb 21, 2023
Tumors Trial in Japan, Korea, Republic of, Taiwan (BI 754091, BI 754111)
Active, not recruiting
- Neoplasms
- BI 754091
- BI 754111
-
Chiba, Kashiwa, Japan
- +12 more
Aug 9, 2022
Advanced Cancer, Pain Trial in Boston (I-STAMP)
Not yet recruiting
- Advanced Cancer
- Pain
- I-STAMP
-
Boston, MassachusettsDana Farber Cancer Institute
Oct 31, 2023
Metastatic Colorectal Cancer Trial in Nanchang (Fruquintinib)
Recruiting
- Metastatic Colorectal Cancer
-
Nanchang, Jiangxi, ChinaThe First Affiliated Hospital of Nanchang University
Nov 1, 2023
Osteoporosis, Sarcopenia, Esophageal Cancer Trial (esophagectomy)
Not yet recruiting
- Osteoporosis
- +2 more
- esophagectomy
- (no location specified)
Apr 12, 2023
Prostate Cancer, Advanced Prostate Carcinoma Trial in San Francisco (Hyperpolarized C13, Magnetic Resonance Imaging (MRI))
Recruiting
- Prostate Cancer
- Advanced Prostate Carcinoma
- Hyperpolarized C13
- Magnetic Resonance Imaging (MRI)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 27, 2022
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Shanghai (Primary debulking surgery,
Not yet recruiting
- Epithelial Ovarian Cancer
- +2 more
- Primary debulking surgery
- +2 more
-
Shanghai, Shanghai, China
- +3 more
Aug 25, 2020
Obesity, Childhood Obesity Trial in Knoxville (FBT, FBT+Variety)
Recruiting
- Obesity
- Childhood Obesity
- FBT
- FBT+Variety
-
Knoxville, TennesseeHealthy Eating and Activity Lab, University of Tennessee
Oct 30, 2022
Prostate Cancer Trial in Hefei (18F-PSMA-1007 PET/CT based on diagnostic model)
Not yet recruiting
- Prostate Cancer
- 18F-PSMA-1007 PET/CT based on diagnostic model
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of USTC
Dec 6, 2022
Education, Oncology, Immune Trial in Taipei (Immunotherapy Special Training Course (ISTC), Advanced Oncology Nurse Training
Recruiting
- Education
- +2 more
- Immunotherapy Special Training Course (ISTC)
- Advanced Oncology Nurse Training Course (AONTC)
-
Taipei, TaiwanNational Taiwan University
Feb 20, 2023
SOX2 & PDL1 Expression on Urinary Bladder Carcinoma
Not yet recruiting
- Urinary Bladder Neoplasm
- (no location specified)
Jun 17, 2022
NSCLC Trial in Guangzhou (BL-M07D1)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 1, 2023
MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)
Not yet recruiting
- MSS
- Rectal Cancer
- Sintilimab with Interleukin-2
- (no location specified)
Nov 1, 2023
Cancer Survivors Trial in Albuquerque (Fitbit Intervention)
Recruiting
- Cancer Survivors
- Fitbit Intervention
-
Albuquerque, New MexicoUniversity of New Mexico
Nov 23, 2022
Caregiver Burden Among Family Caregivers of Patients With Cancer
Completed
- Caregivers
- Cancer
- Questionnaire
-
Burbank, California
- +3 more
Nov 10, 2020
A Population-based, Multicenter Cohort Study of Combined
Not yet recruiting
- Digestive Disease
- Gastroenteroscopy；Risk factor investigation; FIT-HP;RNF180 and SEPTIN9 gene methylation test
- Risk factor investigation;
- (no location specified)
Aug 10, 2023
Ovarian Tumors, Ovarian Epithelial Cancer Trial in Czechia, Poland (DCVAC/OvCa with Standard of Care, DCVAC/OvCa sequentially
Completed
- Ovarian Neoplasms
- Ovarian Epithelial Cancer
- DCVAC/OvCa with Standard of Care
- +2 more
-
Brno, Czechia
- +12 more
May 3, 2022
Breast Tumor, Early-Stage Breast Cancer, Self-Management Trial in Basel, Bern (CTS-BC-CH)
Completed
- Breast Neoplasm
- +4 more
- CTS-BC-CH
-
Basel, Switzerland
- +1 more
Aug 21, 2020
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Terminated
- Metastatic Colon Adenocarcinoma
- +27 more
- Binimetinib
- +3 more
-
San Francisco, California
- +1 more
Jan 5, 2023
Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy Trial (chemo combined with PD-1 inhibitors)
Not yet recruiting
- Esophageal Squamous Cell Carcinomas
- +3 more
- chemotherapy combined with PD-1 inhibitors
- (no location specified)
Nov 17, 2022
Analytical Specificity of Bladder EpiCheck Test in Healthy
Completed
- Non Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Urothelial Carcinoma
- Bladder EpiCheck
-
San Antonio, TexasUrology San Antonio
Sep 3, 2023
Postoperative Complications, Anxiety, Depression Trial in Seoul (Quality of Recovery -15)
Withdrawn
- Postoperative Complications
- +3 more
- Quality of Recovery -15
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 5, 2022